Free Trial

60 Degrees Pharmaceuticals (SXTPW) Competitors

$0.06 0.00 (0.00%)
As of 07/11/2025 01:09 PM Eastern

SXTPW vs. ATNFW, DRTSW, WENAW, APLMW, BCTXW, CDIOW, CTCXW, CELUW, CEROW, and CINGW

Should you be buying 60 Degrees Pharmaceuticals stock or one of its competitors? The main competitors of 60 Degrees Pharmaceuticals include 180 Life Sciences (ATNFW), Alpha Tau Medical (DRTSW), Anew Medical (WENAW), Apollomics (APLMW), BriaCell Therapeutics (BCTXW), Cardio Diagnostics (CDIOW), Carmell (CTCXW), Celularity (CELUW), CERo Therapeutics (CEROW), and Cingulate (CINGW). These companies are all part of the "biotechnology" industry.

60 Degrees Pharmaceuticals vs. Its Competitors

180 Life Sciences (NASDAQ:ATNFW) and 60 Degrees Pharmaceuticals (NASDAQ:SXTPW) are both medical companies, but which is the superior investment? We will contrast the two companies based on the strength of their risk, analyst recommendations, valuation, earnings, institutional ownership, profitability, media sentiment and dividends.

In the previous week, 180 Life Sciences and 180 Life Sciences both had 1 articles in the media. 180 Life Sciences' average media sentiment score of 1.87 equaled 60 Degrees Pharmaceuticals'average media sentiment score.

Company Overall Sentiment
180 Life Sciences Very Positive
60 Degrees Pharmaceuticals Very Positive

Company Net Margins Return on Equity Return on Assets
180 Life SciencesN/A N/A N/A
60 Degrees Pharmaceuticals N/A N/A N/A

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
180 Life SciencesN/AN/AN/AN/AN/A
60 Degrees Pharmaceuticals$665.45KN/AN/AN/AN/A

Summary

60 Degrees Pharmaceuticals beats 180 Life Sciences on 1 of the 1 factors compared between the two stocks.

Get 60 Degrees Pharmaceuticals News Delivered to You Automatically

Sign up to receive the latest news and ratings for SXTPW and its competitors with MarketBeat's FREE daily newsletter.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding SXTPW and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

SXTPW vs. The Competition

Metric60 Degrees PharmaceuticalsBiotechnology IndustryMedical SectorNASDAQ Exchange
Market CapN/A$129.25M$5.62B$9.10B
Dividend YieldN/A3.74%5.24%4.00%
P/E RatioN/A3.4728.1820.27
Price / SalesN/A4,141.03428.7098.48
Price / CashN/A13.1937.4658.16
Price / BookN/A42.088.045.49
Net IncomeN/A-$92.15M$3.19B$250.45M
7 Day PerformanceN/A1.38%3.62%4.79%
1 Month PerformanceN/A4.52%4.06%7.68%
1 Year PerformanceN/A174.83%30.00%16.43%

60 Degrees Pharmaceuticals Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
SXTPW
60 Degrees Pharmaceuticals
N/A$0.06
flat
N/AN/A$0.00$665.45K0.002Gap Up
ATNFW
180 Life Sciences
N/A$0.01
-4.8%
N/A-2.4%$0.00N/A0.007Positive News
Gap Down
DRTSW
Alpha Tau Medical
N/A$0.27
-1.8%
N/AN/A$0.00N/A0.0080Positive News
WENAW
Anew Medical
N/A$0.04
-0.3%
N/AN/A$0.00N/A0.00N/AGap Down
APLMW
Apollomics
N/A$0.03
-22.7%
N/A+184.4%$0.00N/A0.0059Positive News
Gap Up
BCTXW
BriaCell Therapeutics
N/A$0.08
+5.6%
N/A-62.1%$0.00N/A0.008
CDIOW
Cardio Diagnostics
N/A$0.02
flat
N/A-66.8%$0.00$19.90K0.007Gap Down
High Trading Volume
CTCXW
Carmell
N/A$0.03
+6.8%
N/A-67.0%$0.00$32.84K0.0014Gap Up
CELUW
Celularity
N/A$0.04
-0.3%
N/AN/A$0.00$54.22M0.00220Gap Up
High Trading Volume
CEROW
CERo Therapeutics
N/A$0.02
+29.3%
N/A-7.0%$0.00N/A0.008
CINGW
Cingulate
N/A$0.06
+6.7%
N/A+267.0%$0.00N/A0.0020Gap Down

Related Companies and Tools


This page (NASDAQ:SXTPW) was last updated on 7/12/2025 by MarketBeat.com Staff
From Our Partners